,
your personalized virtual assistant to find clinical trials. Go head, 
Carrie Smith
Gabrail Cancer CenterCanton, Ohio - 44718 Gabrail Cancer Center Research LLCCanton, Ohio - 44718 (330-492-3345) |
- CLINICAL TRIALS 9
- CONDITIONS12
- INTERVENTIONS14
- SINCE2004
Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
April 2009 - June 2012
Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer
December 2006 - December 2011
A Study of MM-111 in Combination With (Herceptin) Trastuzumab in Patients With Advanced Her2 Positive Breast Cancer
March 2010 - March 2012
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
June 2010 - June 2012
Efficacy of 6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
May 2004 -
A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-Cell or Follicular Non-Hodgkin's Lymphoma (RATE)
July 2008 - February 2011
Phase III Lucanix Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
July 2008 - October 2011
Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain
May 2010 - December 2011
A Study Evaluating the Clinical Benefit of Adding Custirsen to Docetaxel Retreatment/Prednisone as Second Line Therapy in Men With Castrate Resistant Prostate Cancer (CRPC)
March 2010 - June 2013
Breast Neoplasms
Lung Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Prostatic Neoplasms
Neoplasms
Ovarian Neoplasms
Carcinoma
Carcinoma, Non-Small-Cell Lung
Melanoma
Lymphoma, Follicular
Pain
Placebo
Rituximab
Bavituximab
Gm-Csf
Oncovexgm-Csf
Stimuvax
Placebo Comparator
Mm-111 And Herceptin (Trastuzumab)
Paclitaxel / Carboplatin
Å6 Subcutaneous Injection
Lucanix™
Hydrocodone Bitartrate
Custirsen Sodium
Isotonic, 0.9% Sodium Chloride
